Vallon Pharmaceuticals, Inc. VLON
0.40 +0.40
Day range unavailable
52-week range unavailable
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Virtu Financial LLC | 0.79% | 106,120 | 30.77K | Dec 30, 2022 |
| Two Sigma Investments, LP | 0.47% | 62,836 | 18.22K | Dec 30, 2022 |
| Two Sigma Securities, LLC | 0.27% | 36,604 | 10.62K | Dec 30, 2022 |
| Geode Capital Management, LLC | 0.16% | 21,569 | 6.25K | Dec 30, 2022 |
| UBS Group AG | 0.15% | 20,347 | 5.90K | Dec 30, 2022 |
| State Street Corporation | 0.14% | 18,921 | 5.49K | Dec 30, 2022 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.17% | 22,146 | 6.32K | Sep 29, 2022 |
| Fidelity NASDAQ Composite Index Fund | 0.07% | 9,542 | 2.35K | Nov 29, 2022 |
| Fidelity Extended Market Index Fund | 0.06% | 8,271 | 2.04K | Nov 29, 2022 |
| Fidelity Series Total Market Index Fund | 0.03% | 3,451 | 852 | Nov 29, 2022 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAKER DAVID CHARLES | Chief Executive Officer | Purchase | Feb 11, 2021 | 8,843 |
| KELLY LEANNE M | Chief Financial Officer | Purchase | Jun 3, 2021 | 6,250 |
| PAYNE JOSEPH E | Director | Purchase | May 25, 2021 | 861,250 |
| THORELL MARELLA | Director | Stock Award(Grant) | Jun 30, 2022 | 38,023 |